Globe Life Financial Statements (GL)

Globe Lifesmart-lab.ru   2022 2023 2023 2024 2025   LTM ?
Report date 23.02.2023 31.12.2023 28.02.2024 26.02.2025 25.02.2026   07.05.2026
Currency USD USD USD USD USD   USD
Financial report URL  
Revenue, bln rub ? 5 227 5 448 5 448 5 778 5 999   6 078
Operating Income, bln rub 1 102 4 720 1 194 1 327 1 463   1 515
EBITDA, bln rub ? 1 193 0.000 1 297 1 454 1 592   1 609
Net profit, bln rub ? 894.4 970.8 970.8 1 071 1 161   1 177
OCF, bln rub ? 1 422 0.000 1 482 1 402 1 396   1 385
CAPEX, bln rub ? 27.9 0.000 49.6 71.0 142.5   155.6
FCF, bln rub ? 1 394 0.000 1 433 1 331 1 254   1 230
Dividend payout, bln rub 80.5 0.000 84.1 85.5 86.1   65.9
Ordinary share dividend yield, % 0.00% 0.00% 0.00% 0.00% 0.00%   0.00%
Dividend payout ratio, % 9.01% 0.00% 8.67% 7.98% 7.41%   5.60%
OPEX, bln rub 439.0 727.5 446.0 543.6 541.0   799.1
Cost of production, bln rub 3 686 0.000 3 807 3 908 3 995   3 764
R&D, bln rub 0.000 0.000 0.000 0.000 0.000   0.000
Interest expenses, bln rub 90.4 102.3 102.3 127.1 141.2   140.2
Assets, bln rub 25 987 0.000 28 051 29 076 30 814   30 966
Net Assets, bln rub ? 3 950 0.000 4 487 5 306 5 975   6 085
Debt, bln rub 2 077 0.000 2 116 2 740 2 625   457.0
Cash, bln rub 16 710 0.000 18 055 17 405 18 049   439.0
Net debt, bln rub -14 633 0.00 -15 939 -14 666 -15 423   18.0
Ordinary share price, rub 120.6 121.7 121.7 111.5 139.9   115.9
Number of ordinary shares, mln 97.9 96.4 95.1 83.9 80.9   78.4
Market cap, bln rub 11 805 11 729 11 573 9 362 11 308   9 084
EV, bln rub ? -2 828 11 729 -4 366 -5 304 -4 115   9 102
Book value, bln rub -2 068 0 -2 004 -1 681 -1 515   5 594
EPS, rub ? 9.13 10.1 10.2 12.8 14.4   15.0
FCF/share, rub 14.2 0.00 15.1 15.9 15.5   15.7
BV/share, rub -21.1 0.00 -21.1 -20.0 -18.7   71.3
EBITDA margin, % ? 22.8% 0.00% 23.8% 25.2% 26.5%   26.5%
Net margin, % ? 17.1% 17.8% 17.8% 18.5% 19.4%   19.4%
FCF yield, % ? 11.8% 0.00% 12.4% 14.2% 11.1%   13.5%
ROE, % ? 22.6% 21.6% 20.2% 19.4%   19.3%
ROA, % ? 3.44% 3.46% 3.68% 3.77%   3.80%
P/E ? 13.2 12.1 11.9 8.74 9.74   7.72
P/FCF 8.47 8.08 7.03 9.02   7.39
P/S ? 2.26 2.15 2.12 1.62 1.89   1.49
P/BV ? -5.71 -5.77 -5.57 -7.46   1.62
EV/EBITDA ? -2.37 -3.37 -3.65 -2.59   5.66
Debt/EBITDA -12.3 -12.3 -10.1 -9.69   0.01
R&D/CAPEX, % 0.00% 0.00% 0.00% 0.00%   0
CAPEX/Revenue, % 0.53% 0.00% 0.91% 1.23% 2.38%   2.56%
Globe Life shareholders